Retraction
Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation
Paper Information
Record ID:
29249
Author(s):
Journal:
Publication Date:
March 13, 2014
Retraction Date:
April 29, 2021
(4.5 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (28)
28
Total Citations6
Post-Retraction(21.4%)
22
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
2
After 2+ years
1251
Days since retraction (latest)
Updating the Pharmacological Effects of α-Mangostin Compound and Unraveling Its Mechanism of Action: A Computational Study Review
Cecep Suhandi, Gofarana Wilar, Angga Cipta Narsa et al. (9 authors)
Drug Design Development and Therapy
Open Access
Published: Oct 2024
5 citations
5 citations
1251 days after retraction
Evaluation of the effect of menopausal status and BMI on polymorphisms in Fas/Fas L and the risk of breast cancer
Zahra Tahmasebi Fard
Clinical Breast Cancer
Published: Jul 2024
1159 days after retraction
Role of phospholipase A2 in squamous cell carcinoma and breast cancer
C. Thangam, Rozario Cyril, Ramya Sekar et al. (8 authors)
Elsevier eBooks
Published: Jan 2023
612 days after retraction
The role of phospholipase A2 in cancers of the lungs and breast: A new therapeutic approach
C. Arunkumar M.D.S., Ramakrishnan Veerabathiran
Elsevier eBooks
Published: Jan 2023
612 days after retraction
Apoptosis induced anticancer potential of aspirin on A549 Carcinoma Cell
Abu Junaid, Ajay Kumar
International Journal of Health Sciences
Open Access
Published: May 2022
378 days after retraction
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
Abdul S. Qadir, Jean‐Philippe Guégan, Christophe Ginestier et al. (19 authors)
iScience
Open Access
Published: Oct 2021
14 citations
14 citations
183 days after retraction
Tumor expressed CD95 causes suppression of anti-tumor activity of NK cells in a model of triple negative breast cancer
Abdul S. Qadir, Jean‐Philippe Guégan, Christophe Ginestier et al. (19 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Feb 2021
3 citations
3 citations
75 days before retraction
Chitosan nanoparticles loaded with aspirin and 5‐fluororacil enable synergistic antitumour activity through the modulation of NF‐κB/COX‐2 signalling pathway
Peng Wang, Yaping Shen, Liang Zhao
IET Nanobiotechnology
Open Access
Published: Apr 2020
16 citations
16 citations
366 days before retraction
TNF-α induces apoptosis of human nucleus pulposus cells via activating the TRIM14/NF-κB signalling pathway
Hao‐Jie Zhu, Bao Sun, Qiang Shen
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: Jul 2019
27 citations
27 citations
650 days before retraction
Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection
Nidhi Jyotsana, Zhenjiang Zhang, Lauren E. Himmel et al. (5 authors)
Science Advances
Open Access
Published: Jul 2019
65 citations
65 citations
664 days before retraction
Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity
Sudha Neelam, Jessamee Mellon, Amber Wilkerson et al. (4 authors)
Melanoma Research
Open Access
Published: Apr 2019
1 citation
1 citation
755 days before retraction
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
Masahiro Shibata, Kendall Ham, Mohammad Obaidul Hoque
International Journal of Cancer
Open Access
Published: Apr 2018
156 citations
156 citations
1099 days before retraction
Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer
Jingkun Qu, Xixi Zhao, Jizhao Wang et al. (7 authors)
Oncology Letters
Open Access
Published: Jan 2018
25 citations
25 citations
1184 days before retraction
Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer
Rong-Jane Chen, Hsiao-Che Kuo, Li-Hsin Cheng et al. (8 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2018
52 citations
52 citations
1197 days before retraction
Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
Mengmeng Jiang, Jieying Chen, Wenwen Zhang et al. (10 authors)
Frontiers in Immunology
Open Access
Published: Dec 2017
109 citations
109 citations
1231 days before retraction
Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling
Thomas Kolben, Udo Jeschke, Toralf Reimer et al. (9 authors)
Journal of Cancer Research and Clinical Oncology
Published: Nov 2017
17 citations
17 citations
1248 days before retraction
Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients
Xu Liu, Jingkun Qu, Jia Zhang et al. (10 authors)
Medicine
Open Access
Published: Nov 2017
51 citations
51 citations
1275 days before retraction
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity
Kun Chen, Juan Liu, Shuxun Liu et al. (9 authors)
Cell
Open Access
Published: Jul 2017
260 citations
260 citations
1398 days before retraction
Inflammasomes in Inflammation-Induced Cancer
Chu Lin, Jun Zhang
Frontiers in Immunology
Open Access
Published: Mar 2017
89 citations
89 citations
1506 days before retraction
Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6
Qiuyan Liu, Ha Zhu, Chaoxiong Zhang et al. (5 authors)
OncoImmunology
Open Access
Published: Dec 2016
9 citations
9 citations
1588 days before retraction
Age-associated impairment of antitumor immunity in carcinoma-bearing mice and restoration by oral administration of Lentinula edodes mycelia extract
Satoru Ishikawa, Yasunori Matsui, Satoshi Wachi et al. (6 authors)
Cancer Immunology Immunotherapy
Open Access
Published: Jun 2016
17 citations
17 citations
1778 days before retraction
Mouse interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immuno/gene therapy
Xi Yang, Ashlee Tietje, Xianzhong Yu et al. (4 authors)
International Journal of Oncology
Open Access
Published: Apr 2016
4 citations
4 citations
1848 days before retraction
Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy
Forough Yousefi, Seyed Davar Siadat, Alireza Azizi Saraji et al. (7 authors)
Tumor Biology
Published: Nov 2015
11 citations
11 citations
1996 days before retraction
Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment
Wei Pan, Qian Sun, Yang Wang et al. (6 authors)
Tumor Biology
Published: Apr 2015
9 citations
9 citations
2220 days before retraction
Tumour-Infiltrating Lymphocytes (TILs) in Breast Cancer: a Predictive or a Prognostic Marker?
Sathana Dushyanthen, Peter Savas, Karen Willard‐Gallo et al. (6 authors)
Current Breast Cancer Reports
Published: Feb 2015
3 citations
3 citations
2260 days before retraction
The role of CD95 and CD95 ligand in cancer
Marcus E. Peter, A Hadji, Andrea E. Murmann et al. (7 authors)
Cell Death and Differentiation
Open Access
Published: Feb 2015
324 citations
324 citations
2274 days before retraction
Gambogic acid induces apoptosis and inhibits colorectal tumor growth<i>via</i>mitochondrial pathways
Guangming Huang
World Journal of Gastroenterology
Open Access
Published: Jan 2015
39 citations
39 citations
2310 days before retraction
Paper citing Blockade of Fas signaling in breast cancer cells s...
Unknown Authors
Unknown Journal
Published: May 2014
2555 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #29250
Jun 26, 2020Quick Stats
Total Citations:
28
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025